ResearchMoz

Urinary Tract Cancer Global Clinical Trials Review, Q1, 2011

Publisher Name » GlobalData
Published Date » 2011-01-31
No. Of Pages » 24

GlobalData's clinical trial report, “Urinary Tract Cancer Global Clinical Trials Review, Q1, 2011"" provides data on the Urinary Tract Cancer clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Urinary Tract Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. 

Scope

  • Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status and trial success rate
  • Review of key discontinued trials (suspended, withdrawn and terminated)
  • Overview of the enrollment pattern by phase for the past decade
  • Number of clinical trials segmented by key drugs
  • Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.
  • Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute , and others
Reasons to buy

  • Understand the dynamics of a particular indication as a whole
  • Examine the performance of the trials in terms of their status, recruitment, success rates and others
  • Obtain discontinued trial information for trials across the globe
  • Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 3
Introduction 4
Urinary Tract Cancer 4
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials by Country 6
Top Countries Contributing to Clinical Trials in North America 7
Clinical Trials by Phase 8
In Progress Trials by Phase 9
Clinical Trials by Trial Status 10
Subjects Recruited Over a Period of Time 11
Prominent Sponsors 12
Prominent Drug Comparison 13
Clinical Trial Profiles 14
Clinical Trial Overview of Top Companies 14
AEterna Zentaris Inc. 14
Clinical Trial Overview of AEterna Zentaris Inc. 14
Clinical Trial Overview of Top Universities / Institutes / Hospitals 15
Eastern Cooperative Oncology Group 15
Clinical Trial Overview of Eastern Cooperative Oncology Group 15
National Cancer Institute (NCI) 16
Clinical Trial Overview of National Cancer Institute (NCI) 16
University of Wisconsin Carbone Cancer Center 17
Clinical Trial Overview of University of Wisconsin Carbone Cancer Center 17
Tulane University Health Sciences Center 18
Clinical Trial Overview of Tulane University Health Sciences Center 18
Mayo Clinic 19
Clinical Trial Overview of Mayo Clinic 19
Memorial Sloan Kettering Cancer Center 20
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 20

Appendix 21
Abbreviations 21
Definitions 21
Research Methodology 22
Secondary Research 22
About GlobalData 23
Contact Us 23
Disclaimer 23
Source 23

List of Tables


Urinary Tract Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2011* 5
Urinary Tract Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 6
Urinary Tract Cancer Therapeutics Market, Global, Clinical Trials in Progress by Top Countries, 2011* 6
Urinary Tract Cancer Therapeutics Clinical Trials, North America, Top Countries, 2011* 7
Urinary Tract Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2011* 8
Urinary Tract Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011* 9
Urinary Tract Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 10
Urinary Tract Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 11
Urinary Tract Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 12
Urinary Tract Cancer Therapeutics Clinical Trials, Global, Clinical Trial by Prominent Drugs, 2011* 13
Urinary Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AEterna Zentaris Inc., 2011* 14
Urinary Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Cooperative Oncology Group, 2011* 15
Urinary Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute (NCI), 2011* 16
Urinary Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Carbone Cancer Center, 2011* 17
Urinary Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Tulane University Health Sciences Center, 2011* 18
Urinary Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2011* 19
Urinary Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2011* 20

List of Figures


Urinary Tract Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2011* 5
Urinary Tract Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2011* 8
Urinary Tract Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011* 9
Urinary Tract Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 10
Urinary Tract Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 11
Urinary Tract Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 12
Urinary Tract Cancer Therapeutics Clinical Trials, Global, Clinical Trial by Prominent Drugs, 2011* 13
GlobalData Methodology 22

Upcoming Reports:

Methyl Ethyl Ketone (MEK) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2011 - 2018
By - Transparency Market Research
MEK, abbreviation for Methyl Ethyl Ketone, is a popular name in the solvents industry and is a widely preferred solvent for paints and coatings. It is estimated that half of the global demand for MEK comes from the paints and coatings industry. Its unique properties, especially that of a low boiling solvent, make it an ideal solvent for rubber based cements and printing inks, which contribute to its growing demand. The global MEK market is dominated by select manufacturers only, and most of them are concentrated in China. Despite the demand being expected to be low in near...
Labeling And Linkage Agents For Immunoassays And Gene Probes Market- Global Industry Share, Size, Trends, Analysis And Forecasts, 2012 - 2018
By - Transparency Market Research
Immunoassays are useful in detecting the antigen or antibody levels in variety of illnesses. Gene probes discover the DNA makeup of micro organisms that cause infection and gene structure of cellular mutations involved in diseases like cancer, diabetes, coronary disease, among others. Molecular diagnostics is an upcoming science that studies cellular biomarkers related to gene expression and also develops assays to serve companion diagnostic tests to allow physicians provide better treatment for disease.  The segment of diagnostic industry using immunoassays, gene probes,...
Capacitive Sensors Market - Global Industry Analysis, Market Size, Share, Growth, Trends And Forecast, 2012 - 2018
By - Transparency Market Research
Description Capacitive sensors are devices that enable the measurement of the position of a conductive or nonconductive surface. The high-resolution sensing ability of these sensors makes them highly popular in detection and measurement of position, proximity, acceleration, and fluid levels. Currently, capacitive sensing is widely being used in devices like mobile phones, tables, other mobile devices, laptop trackpads, and in many other applications.   The market for these sensors was valued at USD 7 billion in 2012 and is expected to grow at a CAGR of 13-14% from...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

                    

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...